Braun-Bostich & Associates Inc. recently filed their 13F report for the second quarter of 2022, which ended on 2022-06-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
1600 ASHWOOD DR CANONSBURG, PA 15317
As of the latest 13F report, the guru’s equity portfolio contained 64 stocks valued at a total of $38.00Mil. The top holdings were AGG(4.65%), NVR(4.57%), and QQQ(3.63%).
According to GuruFocus data, these were Braun-Bostich & Associates Inc.’s top five trades of the quarter.
iShares Core U.S. Aggregate Bond ETF
The guru established a new position worth 17,581 shares in ARCA:AGG, giving the stock a 4.65% weight in the equity portfolio. Shares traded for an average price of $102.25 during the quarter.
On 08/17/2022, iShares Core U.S. Aggregate Bond ETF traded for a price of $103.1 per share and a market cap of $83.86Bil. The stock has returned -9.47% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
ISHARES TRUST
Braun-Bostich & Associates Inc. reduced their investment in NAS:IEF by 15,403 shares. The trade had a 3.56% impact on the equity portfolio. During the quarter, the stock traded for an average price of $102.23.
On 08/17/2022, ISHARES TRUST traded for a price of $103.87 per share and a market cap of $23.46Bil. The stock has returned -10.49% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
iShares Core MSCI EAFE ETF
Braun-Bostich & Associates Inc. reduced their investment in BATS:IEFA by 22,533 shares. The trade had a 3.37% impact on the equity portfolio. During the quarter, the stock traded for an average price of $63.22.
On 08/17/2022, iShares Core MSCI EAFE ETF traded for a price of $62.69 per share and a market cap of $89.99Bil. The stock has returned -15.22% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, iShares Core MSCI EAFE ETF has a price-earnings ratio of 12.39 and a price-book ratio of 1.50.
ISHARES TRUST
Braun-Bostich & Associates Inc. reduced their investment in NAS:SHV by 10,952 shares. The trade had a 2.6% impact on the equity portfolio. During the quarter, the stock traded for an average price of $109.91.
On 08/17/2022, ISHARES TRUST traded for a price of $110.05 per share and a market cap of $19.51Bil. The stock has returned -0.09% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
First Trust TCW Opportunistic Fixed Income ETF
Braun-Bostich & Associates Inc. reduced their investment in NAS:FIXD by 16,074 shares. The trade had a 1.71% impact on the equity portfolio. During the quarter, the stock traded for an average price of $47.06.
On 08/17/2022, First Trust TCW Opportunistic Fixed Income ETF traded for a price of $47.4 per share and a market cap of $3.60Bil. The stock has returned -10.77% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
